PERHA PHARMACEUTICALS
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.perha-pharma.fr
Phosphoproteomic Profile of Children With Down Syndrome
Completed
- Conditions
- Down Syndrome
- Interventions
- Biological: Blood sample
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Perha Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT06279208
- Locations
- 🇫🇷
CHRU de Brest, Brest, France
🇫🇷CHU Grenoble, Grenoble, France
🇫🇷Medilab, Parthenay, France
Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease
Phase 1
Recruiting
- Conditions
- Healthy VolunteersDown SyndromeAlzheimer's Disease
- Interventions
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Perha Pharmaceuticals
- Target Recruit Count
- 120
- Registration Number
- NCT06206824
- Locations
- 🇫🇷
Eurofins Optimed, Gières, France
© Copyright 2025. All Rights Reserved by MedPath